Literature DB >> 284722

Urinary excretion of dimethyltryptamine in liver disease.

S A Checkley, M C Oon, R Rodnight, M P Murphy, R S Williams, J L Birley.   

Abstract

The urinary excretion of N,N-dimethyltryptamine (DMT) was higher in patients with severe liver disease than in normal subjects. This difference remained significant when patients with all grades of hepatic encephalopathy were excluded. Patients with liver disease whose mental states were normal excreted amounts of DMT similar to those of patients with a hospital diagnosis of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 284722

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  2 in total

1.  CNS tryptamine metabolism in hepatic coma.

Authors:  S N Young; S Lal
Journal:  J Neural Transm       Date:  1980       Impact factor: 3.575

Review 2.  The clinical potential of ademetionine (S-adenosylmethionine) in neurological disorders.

Authors:  T Bottiglieri; K Hyland; E H Reynolds
Journal:  Drugs       Date:  1994-08       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.